Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/2135
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | GEUSENS, Piet | - |
dc.contributor.author | Reid, D | - |
dc.date.accessioned | 2007-11-11T20:48:38Z | - |
dc.date.available | 2007-11-11T20:48:38Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 19(6). p. 983-989 | - |
dc.identifier.issn | 1521-6942 | - |
dc.identifier.uri | http://hdl.handle.net/1942/2135 | - |
dc.description.abstract | Drug treatment of osteoporosis is based on the knowledge of mechanisms of bone turnover and the manipulation of the cellular components of bone turnover in terms of recruitment, activation and apoptosis of the cells involved. Based on their mechanisms of action, drugs used in the treatment of osteoporosis can be divided into those that inhibit bone turnover (bisphosphonates, SERMs, calcitonin), those that stimulate bone turnover (parathyroid hormone), and those with mixed effects (strontium ranelate). In this chapter we discuss the anti-fracture effects of some newer drugs together with innovative aspects of intake (monthly oral intake for ibandronate) or mechanisms of action (parathyroid hormone and strontium ranelate). Some new drugs that are being studied for their potential anti-fracture effects are listed. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BAILLIERE TINDALL | - |
dc.subject.other | strontium ranelate; ibandronate; zoledronate; parathyroid hormone; RANKL; calcitonin | - |
dc.title | Newer drug treatments: Their effects on fracture prevention | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 989 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 983 | - |
dc.identifier.volume | 19 | - |
local.format.pages | 7 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Univ Hasselt, Inst Biomed Res, Diepenbeek, Belgium. Univ Hosp, Dept Rheumatol, NL-6202 AZ Maastricht, Netherlands. Univ Aberdeen, Med Sch Foresterhill, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland.Geusens, P, Univ Hasselt, Inst Biomed Res, Campus Diepenbeek, Diepenbeek, Belgium.piet.geusens@scarlet.be | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1016/j.berh.2005.07.003 | - |
dc.identifier.isi | 000233858700009 | - |
item.fullcitation | GEUSENS, Piet & Reid, D (2005) Newer drug treatments: Their effects on fracture prevention. In: BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 19(6). p. 983-989. | - |
item.fulltext | No Fulltext | - |
item.validation | ecoom 2006 | - |
item.contributor | GEUSENS, Piet | - |
item.contributor | Reid, D | - |
item.accessRights | Closed Access | - |
crisitem.journal.issn | 1521-6942 | - |
crisitem.journal.eissn | 1521-1770 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
9
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
9
checked on Sep 24, 2024
Page view(s)
54
checked on Jun 28, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.